medigraphic.com
SPANISH

Cirugía Cardiaca en México

ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 2

<< Back Next >>

Cir Card Mex 2019; 4 (2)

Ventricular assistance with extracorporeal membrane oxygenation (ECMO) in patients with with refractory cardiogenic shock after congenital cardiac surgery

Miranda-López D, Benita-Bordes A, Juanico-Enríquez A, Gilles-Herrera C, Arrieta-Arrollo G, Ramírez-Marroquín S
Full text How to cite this article

Language: English
References: 8
Page: 48-50
PDF size: 160.05 Kb.


Key words:

Cardiac surgery, Congenital heart disease, ECMO.

ABSTRACT

Objective. To share the experience of the Instituto Nacional de Cardiología "Dr. Ignacio Chávez " utilizing ECMO as ventricular assistance in pediatric patients. Material. The files of patients undergoing cardiac surgery from May 2014 to May 2018 were reviewed. Only patients under 18 years old requiring veno-arterial ECMO, were included. The methodology used was non-experimental, transversal and descriptive. Results. From January 2014 to May 2018, 17 ECMO veno-arterial systems were installed, 12 by central cannulation and 5 with peripheral cannulation. The age range goes from 1 day to 15 years, and corporal weight from 2.9 kg to 26.7 kg. The average duration of ventricular support was 6 days (range, 2 to 13 days), length of stay in intensive care unit was 8.8 days (range, 1 to 30 days). Nine patients died (53%), 6 died in the first 2 years (85%) and 3 died in the next 2 years (30%). Conclusion. The complexity of congenital heart disease has increased progressively. Therefore, centers such as ours providing a high-level care, ECMO is becoming more and more frequent. The number of cases is still small. However, it is important to raise awareness of them. Initially mortality was high, decreasing significantly in the last two years.


REFERENCES

  1. Segura S, Cambra FJ, Moreno J, et al. ECMO: experiencia en edad pediátrica. AnPediatr 2009; 70:12-19.

  2. Bowen FW, Carboni AF, O´Hara ML, et al. Application of “double bridge mechanical”resuscitation for profound cardiogenic shock leading to cardiac transplantation.Ann Thorac Surg 2001;72:86-90.

  3. Magovern GJ Jr, Simpson KA. Extracorporeal membrane oxygenation for adultcardiac support: the Allegheny experience. Ann Thorac Surg 1998;68:655-61.

  4. Kitamura M, Aomi S, Hachida M, Nishida H, Endo M, Koyanagi H. Current strategyof temporary circulatory support for severe cardiac failure after operation.Ann Thorac Surg 1999;68:662-5.

  5. Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS. Extra Extracorporeal membraneoxygenation support for adult postcardiotomy cardiogenic shock. Ann ThoracSurg 2002;73:538-45.

  6. Sánchez Luna M, Vázquez Estévez J, Blanco Bravo D, et al. Extracorporeal membraneoxygenation, ECMO. Experience with the first 22 cases. An Esp Pediatr1999;51:677-83. [Article in Spanish].

  7. Baran DA. Extracorporeal Membrane Oxygenation (ECMO) and the Critical CardiacPatient. Curr Transplant Rep 2017; 4: 218–225.

  8. Hsu PS, Chen JL, Hong GJ, et al. Extracorporeal membrane oxygenation for refractorycardiogenic shock after cardiac surgery: predictors of early mortality andoutcome from 51 adult patients. Eur J Cardiothorac Surg 2010;37:328-33.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Card Mex. 2019;4